SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001078782-19-000177
Filing Date
2019-02-26
Accepted
2019-02-26 15:29:52
Documents
3
Period of Report
2019-02-20
Items
Item 5.01: Changes in Control of Registrant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K CURRENT REPORT f8k022519_8k.htm 8-K 16339
2 EXHIBIT 10.1 PREFERRED STOCK PURCHASE AGREEMENT f8k022519_ex10z1.htm EX-10.1 9661
3 IMAGE f8k0225198k1.jpg GRAPHIC 51378
  Complete submission text file 0001078782-19-000177.txt   97566
Mailing Address 45 ROCKEFELLER PLAZA 20TH FLOOR, STE 83 NEW YORK NY 10022
Business Address 45 ROCKEFELLER PLAZA 20TH FLOOR, STE 83 NEW YORK NY 10022 (212) 751-0001
AXIM BIOTECHNOLOGIES, INC. (Filer) CIK: 0001514946 (see all company filings)

IRS No.: 274092986 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-54296 | Film No.: 19633175
SIC: 2834 Pharmaceutical Preparations